Home  >  Products  >  BMP4 (bone morphogenetic protein 4 ) Blocking Peptide (the N terminal of BMP4)(100ug)
BMP4 (bone morphogenetic protein 4 ) Blocking Peptide (the N terminal of BMP4)(100ug)

BMP4 (bone morphogenetic protein 4 ) Blocking Peptide (the N terminal of BMP4)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-BMP4 Antibody (ARP63063_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63063
Size: 100ug
Weight: 45kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: The protein encoded by this gene is a member of the bone morphogenetic protein family which is part of the transforming growth factor-beta superfamily. The superfamily includes large families of growth and differentiation factors. Bone morphogenetic proteins were originally identified by an ability of demineralized bone extract to induce endochondral osteogenesis in vivo in an extraskeletal site. This particular family member plays an important role in the onset of endochondral bone formation in humans, and a reduction in expression has been associated with a variety of bone diseases, including the heritable disorder Fibrodysplasia Ossificans Progressiva. Alternative splicing in the 5' untranslated region of this gene has been described and three variants are described, all encoding an identical protein.
Alternative names: BMP2B; BMP2B1; MCOPS6; OFC11; ZYME
See Full Product Listings >